BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright ©The Author(s) 2025.
World J Psychiatry. Dec 19, 2025; 15(12): 111180
Published online Dec 19, 2025. doi: 10.5498/wjp.v15.i12.111180
Table 1 Comparison of participants’ general information, n (%)
Group
Age (years)
Gestational weeks (weeks)
Neonatal gender
Newborn weight (kg)
Female
Male
Control group (n = 134)25.60 ± 3.3939.98 ± 0.9269 (51.49)65 (48.51)3.49 ± 0.17
Observation group (n = 134)26.28 ± 3.0839.96 ± 0.9575 (55.97)59 (44.03)3.52 ± 0.23
t/χ21.7150.1960.5401.298
P value0.0870.8450.4620.196
Table 2 Comparison of clinical efficacy between the two groups, n (%)
Group
n
Markedly effective
Effective
Invalid
Total effective rate
Control group13431 (23.13)82 (61.19)21 (15.67)113 (84.33)
Observation group13491 (67.91)36 (26.87)7 (5.22)127 (94.78)
χ27.817
P value0.005
Table 3 Comparison of hemorrhoid diameter and edema in patients (mean ± SD)
GroupnDiameter of hemorrhoids (cm)
Edema degree (points)
Before treatment
Treatment for 14 days
Before treatment
Treatment for 14 days
Control group1341.70 ± 0.310.75 ± 0.223.05 ± 0.691.57 ± 0.50
Observation group1341.71 ± 0.310.46 ± 0.123.08 ± 0.811.37 ± 0.49
χ20.13813.3990.3253.232
P value0.890< 0.0010.7460.001
Table 4 Comparison of compliance between the two groups, n (%)
Group
n
Full compliance
Partial compliance
Noncompliance
Total adherence rate
Control group13478 (58.21)35 (26.12)21 (15.67)113 (84.33)
Observation group13494 (70.15)34 (25.37)6 (4.48)128 (95.52)
χ29.267
P value0.002
Table 5 Comparison of the Self-rating Anxiety Scale and Self-rating Depression Scale scores between the groups (mean ± SD)
Group
n
SAS
SDS
Before treatment
Treatment for 7 days
Treatment for 14 days
Before treatment
Treatment for 7 days
Treatment for 14 days
Control group13439.42 ± 3.4435.98 ± 2.0730.38 ± 2.1537.63 ± 3.7233.96 ± 2.2229.35 ± 2.87
Observation group13439.22 ± 3.5133.54 ± 2.7628.93 ± 3.2937.40 ± 3.5231.86 ± 2.4627.64 ± 2.63
t0.4578.2004.2670.5407.3555.082
P value0.648< 0.001< 0.0010.590< 0.001< 0.001
Table 6 Comparison of the incidence of adverse reactions between the two groups, n (%)
Group
n
Itching
Redness and swelling
Skin damage
Abnormal pain
Overall incidence rate
Control group1343 (2.24)4 (2.99)1 (0.75)2 (1.49)10 (7.46)
Observation group1342 (1.49)3 (2.24)1 (0.75)1 (0.75)7 (5.22)
χ20.565
P value0.452